| Announce Date | 11/13/2025 |
| EPS Normalized Actual | $-0.13 (Miss by $-0.04) |
| EPS GAAP Actual | $-0.13 (Miss by $-0.04) |
| Revenue Actual | $0.00145B |
| Revenue Surprise | Beat by $1.45M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.11 |
| EPS GAAP Estimate | $-0.11 |
| Revenue Estimate | $0.0012B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.14 | -0.04 | 0.00145B | 73.1% | 0.67M |
| FQ2 2025 (Jun 2025) | -0.14 | 0.01 | 0.00109B | 72.75% | 0.34M |
| FQ1 2025 (Mar 2025) | -0.16 | -0.16 | 0.000737825B | 67.88% | 0.74M |
| FQ1 2023 (Mar 2023) | -0.15 | -0.15 | 7.5E-5B | 100% | 0.08M |
| FQ2 2023 (Jun 2023) | -0.15 | -0.15 | 0.000138B | 100% | 0.14M |
| FQ3 2023 (Sep 2023) | -0.078 | -0.078 | 0.000254B | 100% | 0.25M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 0.00014B | 100% | 0.14M |
| FQ1 2024 (Mar 2024) | -0.12 | -0.12 | 0.000237B | 68.35% | 0.24M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.11
Consensus Revenue Estimates
0.0012B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -0.05 | -- | -0.05054622 | -0.04945378 | 1 |
| FQ3 2027 (Sep 2027) | -0.06 | -- | -0.06065546 | -0.05934454 | 1 |
| FQ2 2027 (Jun 2027) | -0.06 | -- | -0.06065546 | -0.05934454 | 1 |
| FQ1 2027 (Mar 2027) | -0.09 | -- | -0.09098319 | -0.08901681 | 1 |
| FQ4 2026 (Dec 2026) | -0.09 | -- | -0.09 | -0.09 | 1 |
| FQ3 2026 (Sep 2026) | -0.1 | -40 | -0.1 | -0.1 | 1 |
| FQ2 2026 (Jun 2026) | -0.11 | -27.27 | -0.11 | -0.11 | 1 |
| FQ1 2026 (Mar 2026) | -0.11 | -45.45 | -0.11 | -0.11 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0B | -- | 0B | 0B | 1 |
| FQ3 2027 (Sep 2027) | 0B | -- | 0B | 0B | 1 |
| FQ2 2027 (Jun 2027) | 0B | -- | 0B | 0B | 1 |
| FQ1 2027 (Mar 2027) | 0B | -- | 0B | 0B | 1 |
| FQ4 2026 (Dec 2026) | 0B | -- | 0B | 0B | 1 |
| FQ3 2026 (Sep 2026) | 0B | 9.38 | 0B | 0B | 1 |
| FQ2 2026 (Jun 2026) | 0B | 12.8 | 0B | 0B | 1 |
| FQ1 2026 (Mar 2026) | 0B | 38.51 | 0B | 0B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
6
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.1 | -0.14 | -0.04 | 28.57% |
| FQ2 2025 (Jun 2025) | -0.15 | -0.14 | 0.01 | -7.14% |
| FQ1 2025 (Mar 2025) | -0.16 | -0.16 | 100% | |
| FQ1 2023 (Mar 2023) | -0.15 | -0.15 | 100% | |
| FQ2 2023 (Jun 2023) | -0.15 | -0.15 | 100% | |
| FQ3 2023 (Sep 2023) | -0.078 | -0.078 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | -0.12 | -0.12 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $0B | $0.67M | 46.21% |
| FQ2 2025 (Jun 2025) | $0B | $0B | $0.34M | 31.19% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0.74M | 100% |
| FQ1 2023 (Mar 2023) | $0B | $0B | $0.08M | 100% |
| FQ2 2023 (Jun 2023) | $0B | $0B | $0.14M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $0B | $0.25M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0.14M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0B | $0.24M | 100% |